First shipment of AstraZeneca vaccine arrives amid confusion over its use for seniors
OTTAWA — The first doses of the Oxford-AstraZeneca COVID-19 vaccine are set to arrive in Canada today as confusion persists over who should get it.
Canada is to receive 500,000 doses of the vaccine, the third approved for use in Canada, from the Serum Institute of India.
But questions about who should receive the Oxford-AstraZeneca vaccine continue amid conflicting guidance about its use.
Health Canada last week authorized its use for all adult Canadians but the National Advisory Committee on Immunization recommended Tuesday that it not be administered to people 65 years of age or older.